Successful administration of measles-rubella-mumps vaccine by graded challenge in a case with anaphylaxis after prior

Tuba Tuncel1, Ozlem Sancakli2, Ece Ozdogru2

  • 1Izmir Katip Celebi University Medical Faculty, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Izmir Tepecik Training and Research Hospital, Department of Pediatrics. Izmir, Turkey. ttuncel@yahoo.com.tr.

Insights

Egg allergy is common in children. A patient with a history of anaphylaxis after the measles-mumps-rubella (MMR) vaccine successfully received a gradually increased dose, challenging contraindication guidelines.

Area of Science:

  • Pediatric Allergy and Immunology
  • Vaccinology
  • Immunology

Background:

  • Egg allergy is a prevalent childhood food allergy, often co-occurring with cow's milk allergy.
  • The measles-mumps-rubella (MMR) vaccine, a standard pediatric immunization, contains egg protein, necessitating careful administration in allergic individuals.
  • Current guidelines recommend single-dose MMR vaccination under medical observation for egg-allergic patients.

Observation:

  • Anaphylaxis is a severe allergic reaction that can occur post-vaccination.
  • A history of anaphylaxis to a vaccine is typically considered a contraindication for future doses.
  • This case involved a patient who experienced anaphylaxis after a previous MMR vaccination.

Findings:

  • Successful administration of the MMR vaccine was achieved using a protocol of gradually increased doses.
  • The patient tolerated the incremental dosing schedule without recurrent anaphylaxis.
  • This approach demonstrates a potential alternative for vaccinating high-risk individuals.

Implications:

  • Gradual dose escalation may be a viable strategy for MMR vaccination in egg-allergic patients with a history of anaphylaxis.
  • This challenges the absolute contraindication of previous anaphylaxis for MMR vaccination.
  • Further research is warranted to validate this approach in a larger cohort.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Allergic Reactions02:06

Allergic Reactions

Overview
33.1K
Vaccinations01:51

Vaccinations

Overview
52.8K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
70
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Cross-reactivity00:42

Cross-reactivity

Overview
33.6K